The US drugmaker, which has partnered with Germany#39;s BioNTech on the vaccine, estimates delivering 2.1 billion doses, generating $33.5 billion in sales. The company#39;s May forecast was for $26 billion in sales.
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
In July, HCL Technologies had announced a Rs 4,000 crore buyback programme for FY19 at a price of Rs 1,100 per equity share.
No comments:
Post a Comment